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A Basic Overview of Penicillins
and Their Use in Small Animal Medicine
by Janel Ames *
There are many factors to consider when
deciding upon antimicrobial therapy. Some of
them are suspected etiology, host status, organ
system affected, and the properties of the drug
being considered. Iv1icrobicidal drugs, such as
penicillin, are superior to bacteriostatic drugs
in immunosuppressed patients, severe and/or
overwhelming infections where rapid action is
required, and for long-standing infections to
eliminate the pathogen, preventing carrier
states or relapses. 1
Due to the thick cell wall of bacteria and
their capability of concentrating solutes, bac-
teria have a high intracellular osmolality.
Penicillin causes cell wall defects by inactivat-
ing bacterial transpeptidase, which prevents
the maintenance of an osmolar gradient,
causing formation of spheroblasts, cell lysis,
and death. 1
Many penicillins have been developed.
They can be divided into; natural penicillins,
semi-synthetic penicillins such as penicil-
linase-resistant penicillins, broad spectrum
(amino-) penicillins, and antipseudomonas
and extended spectrum penicillins (See table
one).
Natural penicillins
Natural penicillins (e. g. penicillin G, peni-
cillin V, and phenethicillin) were some of the
original penicillins produced. They have a
limited range of activity and are highly sus-
ceptible to beta-lactamases which are pro-
duced by many staphylococci and Gram-
negative bacteria. They are also inactivated
by gastric acid. These are efficacious only
against Gram-positive bacteria. 2 ,3
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Penicillinase-resistant penicillins
Penicillinase-resistant penicillins (e. g.
methicillin, naficillin, cloxicillin, dicloxicillin,
and oxacillin) were developed by adding sub-
stituents onto the aromatic ring of penicillin to
sterically inhibit beta-Iactamases. 2 Methicillin
was the first semisynthetic penicillin devel-
oped but is poorly absorbed orally due to gas-
tric acid instability, and is not very potent. All
of the later developed drugs in this group are
well absorbed orally except for naficllin. All of
these are effective against Gram-positive beta-
lactamase producing bacteria. 4
Temocillin is a recently developed penicil-
linase-resistant penicillin which is active
against almost all Gram-negative bacteria ex-
cept Pseudomonas. Because of this, it is effective
in treating coliform infections, especially en-
teritis and mastitis. It is poorly absorbed
orally, but when administered parenterally it
has an unusually long half-life in humans. s
Broad-spectrum penicillins
The broad spectrum penicillins (e. g. ampi-
cillin, amoxicillin, and hetacillin) are a very
important group of drugs due to their activity
against both Gram-positive and some Gram-
negative organisms. They are, however, sus-
ceptible to penicillinase. This group is stable
in gastric acid, and therefore effective orally.
Amoxicillin and ampicillin have equal activ-
ity, but an10xicillin is absorbed better orally
and has more rapid action. 2 Hetacillin is inac-
tive as it exists in a preparation, but is n10re
stable in gastric acid then amoxicillin and am-
picillin' and therefore it is absorbed best. Af-
ter it enters the circulation, it is metabolized
to ampicillin and becomes active. Amoxicillin
and ampicillin are two of the most widely used
penicillins because of their wide range of ac-
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TABLE ONE: Properties of penicillin derivatives (taken from Greene4).
Route of Gastric Beta-
Generic Trade Adminis- Acid Lactamase Antimicrobial
Name Name tration Stability Resistance Spectrum
NATURAL PENICILLINS
Penicillin G Many PO, 1M, Poor to fair (20%), No Narrow (gram-positive
IV food decreases organisms)
Penicillin V Many PO Good (60%) No Narrow (gram-positive
organisms)









Nafcillin Unipen, Nafcil 1M, IV Variable (not Yes Narrow (gram-positive,
recommended for beta-lactamase-
oral use) producing organisms)
Cloxacillin Tegopen PO Good Yes Narrow (gram-positive,
beta-lactamase -
producing organisms)
Dicloxacillin Veracillin, Pathocil, PO Good (50%), food Yes Narrow (gram-positive
Dynapen decreases (30 %) beta-lactamase-
producing organisms)




Ampicillin Many PO, 1M, Good (40%), food No Extended (gram-positive
IV decreases cocci, some gram-
negative organisms)
Amoxicillin Omnipen PO, 1M Excellent (75 %) No Extended (gram-positive
cocci, some gram-
negative organisms)














Mezlocillin Mezlin 1M, IV Poor No Greater against gram-
negative organisms
Piperacillin Pipracil 1M, IV Poor No Greater against gram-
negative organisms
PO =oral; 1M =intravenous; IV =intravenous
t Also includes flucloxacillin and floxacillin.
ttAlso includes bacampicillin, cyclacillin, epicillin, pivampicillin, and talampicillin.
§Also includes azlocillin, indamylcarbenicillin, carindacillin, and carfecillin.
34 Iowa State University Veterinarian
tivity and their ability to produce good plasma
concentrations, although at similar dosages
they are less effective than crystalline penicil-
lin G. 1S Other derivatives in this group are
bacampicillin, cyclacillin, epicillin, pivampi-
cillin, and talampicillin. 4
Antipseudomonas and Extended-spectrum
penicillins
Antipseudomonas penicillins (e.g. carbeni-
cillin and ticarcillin) are more active against
Pseudomonas and some anaerobes. They are in-
activated by beta-Iactamases and gastric acid.
Their activity is increased when aminoglyco-
side antibiotics are also given. 4. 7
Penicillanic acid sulfone (sulbactam), 6-ha-
lopenicillanic acids, 6-acetyl methylene peni-
cillanic acid, and naturally occurring clavu-
lanic acid, olivanic acids, and thienamycin
are beta-Iactamase inhibitors that can Dotenti-
ate the penicillin antibiotics. Clavula~ic acid
is an ideal exampIe of this group. It is a po-
tent, irrreversible inhibitor of beta-Iactamase
of staphylococci and many Gram-negative
bacteria. It closely matches its antibiotic
partners, especially amoxicillin, (see figure 1)
and has little antibacterial activity of its own
that might interfere with the action of the in-
tended primary antibiotic. The minimum in-
hibitory concentration required for amoxicil-
lin is markedly reduced when used with
cloxacillin against beta-lactamase producing
isolates. Clavulanic acid's wide range of effec-
tiveness makes it a useful potentiator of many
penicillins. This combination is effective in














Figure 1. Effect of clavulanate potentiation
on the antibacterial spectrum of amoxicillin and
ticarcillin. Taken from: Wishart, David F.: Re-
cent Advances in Antimicrobial Drugs: The
Penicillins.JAVMA 185:1107, 1984.
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skin lesions and pyodermas. The use for soft
tissue, urinary, and respiratory infections in
humans indicates that the use in small ani-
mals may spread in time. S
Sulbactam is also an excellent example of
this class of drugs because it is an irreversible
beta-Iactamase inhibitor, yet provides no use-
ful antibiotic activity. Its main difference
when compared to clavulanic acid is the two
to five-fold decrease in potency. S
Methicillin and cloxacillin can also provide
protection for beta-lactam rings. They com-
pete for the penicillinase allowing a second
"protected" antibiotic (e. g. penicillin G or am-
picillin) to exert its antibacterial effect vir-
tually unhindered. 6 There are four n1ain cri-
teria that are met by these two drugs. They
are as follows: 1) Their action is primarily due
to beta-Iactamase inhibition, 2) The "protec-
tor" drug has a much greater affinity for the
penicillinase than the "protected" drug, 3)
There is little or no hydrolysis of the "protec-
tor" drug by the penicillinase, 4) The "protec-
tor" drug shows no antibacterial activity at the
effective protection concentration.
Staphylococcal penicillinase has a low affin-
ity for methicillin. Therefore, it is not effective
in protection of other penicillins from this
penicillinase. 6
Since most penicillins are excreted in the
urine, the blocking analog probenecid can be
given simultaneously to increase penicillin
serum levels. This offers yet another alterna-
tive method to increase the efficacy of the
penicillins.
Although many types of combination
therapy may sound promising, and often are
very effective, great care must be taken to en-
sure that the substances used together will be
advantageous. For example, penicillins
should never be mixed with blood serum or
other proteinaceous fluids or with'other a~ti­
biotics before they are administered. Penicil-
lins are antagonistic in vivo with tetracyclines
and chloramphenicol. Penicillins are some-
what unpredictable when combined in
therapy with erythromycin, novobiocin, and
lincomycin. No antagonism is seen with sul-
fonamides. There is possible synergism when
penicillins are used with aminoglycosides,
cephalosporins, and polymyxins. 4 Deleterious
drug interactions may have their effect by al-
tering the body's metabolism, excretion, dis-
tribution, or protein binding of one or both
drugs. 4
35
Clinical usage of penicillins
In the interest of providing a practical out-
look on the clinical use of penicillins, several
organ systems and some common problems
and solutions will be discussed next. Although
it is far from a complete guide, it provides a
basic introduction to the use of the penicillins.
The foremost problem in treating upper
respiratory diseases is the large number of
commensal bacteria present. Because of this it
may be very difficult to decide if there is a
bacterial infection that needs to be treated.
Next, one must decide which is' the causative
agent, or agents. Pathogenic upper respira-
tory infectors include staphylococci, bordetel-
lae, and mycoplasmas. Penicillin is often a
good choice for therapy here because of its
penetration of the nasal mucous membranes.
Ampicillin can be effectively used to prevent
secondary infections in cases where the prob-
lem may be neoplasia, fungal infections, or
trauma to the mucosa. 8
In the treatment of lower respiratory tract
infections, in addition to the usual factors one
must use in choosing an antibiotic, such as
susceptibility of the organisms, one must also
consider the permeability of the alveolar
membranes, and the normal tracheobronchial
flora such as streptococci, staphylococci, Pas-
turella multocida) and Klebsiella pneumonia. Dis-
ease states are commonly caused by Klebsiella)
Achromobacter; Pseudomonas) and E. coli. Larger,
highly lipid-soluble antibiotics that contain a
benzene ring generally penetrate bronchial se-
cretions more easily. When also considering
cost and toxicity, ampicillin and amoxicillin
can be considered as a first choice therapy for
most lower respiratory tract infections. 9
Complete urinalysis from urine collected by
cystocentesis is a quick and reliable way to
diagnose urinary tract infection. Tentative
identification of the etiologic agent can come
quickly after inoculating blood agar and Mac-
Conkey agar. Primary pathogenic bacteria
seen are Proteus mirabilis) Staphylococcus spp.,
alpha-hemolytic streptococci, Pseudomonas
spp., E coli) Klebsiella spp., and Enterobacter
spp. Susceptibility tests for all species of bac-
teria present must be done initially, and fre-
quently after therapy has begun, due to the
rapid transfer of resistance within bacterial
populations. Penicillins such as ampicillin are
very effective in cases where susceptibility is
found (especially versus Proteus mirabilis)
staphylococci, and streptococci). This -is be-
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cause of high urine concentrations of the drug
due to renal excretion. Because of the short
half-life of the drug and the renal excretion it
is important to only allow the patient to uri-
nate immediately prior to the next treatment.
Recurrent infections can be avoided by insti-
tuting a long-tern~ low-dose therapy. 10.16
When dealing with canine skin infections
Staphyloccus intermedius is the pathogen most
commonly found. Because of the penicillinase
production by the majority of isolates, beta-
lactamase-resistant penicillins are usually the
first choice for tre~tment if a penicillin is to be
used. Drugs from other classes of antibiotics
such as erythromycin and lincomycin, are of-
ten more effective. Oxacillin has been
described as an excellent drug for the treat-
ment of canine pyodermas. If penicillins are
used, drainage of abcesses, removal of foreign
bodies, and debridement of damaged tissues
must be done to promote bacterial growth,
without which these drugs are quite ineffec-
tive. 11 Anaerobic infections can be treated
with ampicillin or carbenicillin. 16
Feline abcesses normally respond well to in-
jected procaine penicillin G and benzathine
penicillin. If oral therapy is desired, ampicil-
lin and amoxicillin are good choices. 11
A special problem is encountered in cases of
gastroenteritis, because of the high concentra-
tion of the natural microbial flora present.
Overabundance of one of several species of
bacteria is not necessarily indicative of its
etiolgical importance. Some bacteria that are
often seen as specific infectors where anti-
biotic therapy is indicated are Yersinia enteroco-
litica) Campylobacter jejuni) and Salmonella spp. 12
Since these are better treated by non-penicil-
lin antibiotics, the issue will not be persued
further here, but it should be emphasized that
any systemic antimicrobial can alter the G I
flora and removal of beneficial bacteria can
give pathogens an easy route to infection. Any
antimicrobial used, especailly for gastrointes-
tinal disease, must be selective.
Carbenicillin and ticarcillin are used, al-
though infrequently, in ophthalmic disease.
These act with gentamycin against Pseudo-
monas. Ampicillin, amoxicillin, and hetacillin
are sometimes used for intraocular infections
because of their effectiveness against many
different bacteria and their ability to cross the
blood-ocular barrier. Generally the aminogly-
cosides have been found to be much more ef-
fective for treatment. 4,16
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Penicillin and ampicillin are the preferred
antibiotics in neonatal patients. A primary
reason is the abiltiy to sustain low doses for
long periods of time with low probability of
excretion and toxicity problems. 16
Penicillin and naficillin are possible choices
in complex orthopedic cases. Pyoarthritis is
commonly caused by species of Staphylococcus)
Streptococcus) and Mycoplasma. Due to the in-
flammation all antibiotics readily pass into the
capsular fluid. 16 Sensitivity testing will indi-
cate the best choice of therapy.
Antimicrobials have become drugs not only
of use, but also of abuse. Many clients, and
some clinicians, have taken the "give 'em a
dose of penicillin and call me in the morning"
attitude. Although the disease may appear to
indicate penicillin therapy, other factors often
make the therapy ineffective. One must be
aV/are of many variables concerning the host,
the etiologic agent, and the drug. (See figure
2).
The primary concern when considering the
host is the immunological status. Most
therapy is designed to enhance, not replace,
the host's defense mechanisms. When the pa-
tient is severely debilitated not only will the
body's reaction against the microorganism be
lessened, but the reaction to the drug Inay
also be altered. Reduced absorption, distribu-
tion, delivery, metabolism, and excretion may
lead to failure of therapy to improve the pa-
tient's condition, or worse, debilitating the pa-
tient even more. Therefore this must be se-
riously considered. This also means that
supportive therapy must be considered, such
as fluid replacement and correction of electro-
lyte and acid-base balances. In addition this
includes cleaning of the wound to relieve ob-
struction, removal of as much as possible of
the invading disease-causing agent, and re-
moval of debris. 4 •14 This will help to restore
normal function and aid in the healing proc-
ess.
A factor that is neglected in a surprising
nun1ber of cases is the etiologic agent. First
one must establish that there definitely is a
n1icrobiological cause to the disease. Clinical
signs are not enough. For example, inflam-
mation and a febrile state alone are not justifi-
cation for antimicrobial therapy. One must
also consider the possibility of multiple agents
Figure 2: Factors involved in failure of antimicrobial therapy. Adapted from; Greene, Clinical Microbiology and







- poor physical condition
- foreign bodies
Clinician - presumptive diagnosis
- experience, 'best guess'




Compliance - non-compliance to therapy by client
- management variables
Response - foreign bodies
- abscess with poor drainage
- accelerated elimination
-lack of supportive care
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or underlying disease. 4 ,14 Although posItIve
identification and susceptibility testing is not
always required, or sometimes even possible,
it cannot be emphasized enough that this is
the best way to decide upon treatment. One
must not substitute convenience for accuracy.
It has the potential, in the long run, for saving
time and money on unneeded and unhelpful
therapy, and possibly saving the patient's life.
Unfortunately a complete work-up is not al-
ways possible. In these cases knowledge and
experience must be trusted, and close obser-
vation is necessary.
Although superficially it may seem simple
to decide upon a drug for therapy, it is not.
Unfortunately just finding a drug that can su-
press growth of the organism is not enough.
Many questions must be asked. For example:
What is the bio-availability of the drug? Is it
compatible with other drugs being used?
Should short-term or long-term therapy be
administered? What dosage is appropriate?
Only when these questions are answered can
an appropriate drug therapy be decided upon.
As time goes by and more is learned about
the drugs we use, the possibilities for therapy
become seemingly endless. Unfortunately
time also becomes a limiting factor, as it is
impossible for anyone clinician to learn about
them all. Hopefully, though, one can take a
few drugs, such as the more popularly used
penicillins, and learn them thoroughly. One
must remember, though, that it is equally, if
not more important to learn when not to use a
drug than when to use it. A basis for that
knowledge can be built with time and expe-
rIence.
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